95 related articles for article (PubMed ID: 7955686)
41. Characterization of osteosarcoma cells from two sibling large-breed dogs.
Norrdin RW; Powers BE; Torgersen JL; Smith RE; Withrow SJ
Am J Vet Res; 1989 Nov; 50(11):1971-5. PubMed ID: 2619126
[TBL] [Abstract][Full Text] [Related]
42. Periosteal bone formation elicited by partially purified bone morphogenetic protein.
Nakahara H; Takaoka K; Koezuka M; Sugamoto K; Tsuda T; Ono K
Clin Orthop Relat Res; 1989 Feb; (239):299-305. PubMed ID: 2912630
[TBL] [Abstract][Full Text] [Related]
43. [The roentgen findings and pathological basis of parosteal osteosarcoma].
Duan CX
Zhonghua Fang She Xue Za Zhi; 1989 Jun; 23(3):157-60. PubMed ID: 2582907
[TBL] [Abstract][Full Text] [Related]
44. Development of a novel spontaneous metastasis model of human osteosarcoma transplanted orthotopically into bone of athymic mice.
Berlin O; Samid D; Donthineni-Rao R; Akeson W; Amiel D; Woods VL
Cancer Res; 1993 Oct; 53(20):4890-5. PubMed ID: 8402677
[TBL] [Abstract][Full Text] [Related]
45. Roentgenographically "benign" but rapidly lethal diaphyseal osteosarcoma; a case report.
Ellman H; Gold RH; Mirra JM
J Bone Joint Surg Am; 1974 Sep; 56(6):1267-9. PubMed ID: 4530786
[No Abstract] [Full Text] [Related]
46. Parosteal (juxtacortical) osteosarcoma of the distal femur.
Adler CP
Pathol Res Pract; 1980 Nov; 169(3-4):388-95. PubMed ID: 6938939
[No Abstract] [Full Text] [Related]
47. Enhanced expression of type I receptors for bone morphogenetic proteins during bone formation.
Ishidou Y; Kitajima I; Obama H; Maruyama I; Murata F; Imamura T; Yamada N; ten Dijke P; Miyazono K; Sakou T
J Bone Miner Res; 1995 Nov; 10(11):1651-9. PubMed ID: 8592941
[TBL] [Abstract][Full Text] [Related]
48. Histological and radiological analysis of autoclaved bone 2 years after extirpation.
Yamamoto N; Tsuchiya H; Nojima T; Sumiya H; Tomita K
J Orthop Sci; 2003; 8(1):16-9. PubMed ID: 12560880
[TBL] [Abstract][Full Text] [Related]
49. Relationship of bone morphogenetic protein expression during osteoblast differentiation to wild type p53.
Chandar N; Swindle J; Szajkovics A; Kolman K
J Orthop Res; 2005 Nov; 23(6):1345-53. PubMed ID: 15994055
[TBL] [Abstract][Full Text] [Related]
50. Bone formation in vitro and in nude mice by human osteosarcoma cells.
Ogose A; Motoyama T; Hotta T; Watanabe H; Takahashi HE
Virchows Arch; 1995; 426(2):117-25. PubMed ID: 7757281
[TBL] [Abstract][Full Text] [Related]
51. [Effect of human bone morphogenetic protein 2, 3, 6, and 12 on osteosarcoma cell line UMR106].
Li X; He H; Wu L; Ma W; Chen Y; Wei J; Miao J; Zhou L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 May; 35(5):464-9. PubMed ID: 20543470
[TBL] [Abstract][Full Text] [Related]
52. [Radiographic appearance of periosteal osteosarcoma].
Wu CG
Zhonghua Fang She Xue Za Zhi; 1987 Aug; 21(4):222-4. PubMed ID: 2961541
[No Abstract] [Full Text] [Related]
53. [Primary multiple osteogenic sarcoma].
Dreissiger I; Palkonyay G; Balázs A; Serényi P
Magy Traumatol Orthop Helyreallito Seb; 1986; 29(4):305-10. PubMed ID: 2879086
[No Abstract] [Full Text] [Related]
54. Bone induction by Escherichia coli -derived recombinant human bone morphogenetic protein-2 compared with Chinese hamster ovary cell-derived recombinant human bone morphogenetic protein-2.
Bessho K; Konishi Y; Kaihara S; Fujimura K; Okubo Y; Iizuka T
Br J Oral Maxillofac Surg; 2000 Dec; 38(6):645-649. PubMed ID: 11092786
[TBL] [Abstract][Full Text] [Related]
55. The multiple sclerotic osteogenic sarcoma of early childhood.
Cremin BJ; Heselson NG; Webber BL
Br J Radiol; 1976 May; 49(581):416-9. PubMed ID: 1065446
[TBL] [Abstract][Full Text] [Related]
56. Biochemical stability of a bone-inducing substance from murine osteosarcoma.
Yoshikawa H; Takaoka K; Shimizu N; Ono K; Nakata Y; Amitani K
Clin Orthop Relat Res; 1982 Mar; (163):248-53. PubMed ID: 6950822
[TBL] [Abstract][Full Text] [Related]
57. Monoclonal antibody to human osteosarcoma: a novel Mr 26,000 protein recognized by murine hybridoma TMMR-2.
Tsai CC; McGuire MH; Mellitt RJ; Ritter RA; Xu JZ; Litwicki DJ; Roodman ST
Cancer Res; 1990 Jan; 50(1):152-8. PubMed ID: 2293550
[TBL] [Abstract][Full Text] [Related]
58. Medullary involvement in parosteal osteosarcoma. A case report.
Picci P; Campanacci M; Bacci G; Capanna R; Ayala A
J Bone Joint Surg Am; 1987 Jan; 69(1):131-6. PubMed ID: 3468113
[No Abstract] [Full Text] [Related]
59. RANKL directly induces bone morphogenetic protein-2 expression in RANK-expressing POS-1 osteosarcoma cells.
Wittrant Y; Lamoureux F; Mori K; Riet A; Kamijo A; Heymann D; Redini F
Int J Oncol; 2006 Jan; 28(1):261-9. PubMed ID: 16328004
[TBL] [Abstract][Full Text] [Related]
60. Immunohistochemical localization of bone morphogenetic proteins (BMPs) 2, 4, 6, and 7 during induced heterotopic bone formation.
McCullough KA; Waits CA; Garimella R; Tague SE; Sipe JB; Anderson HC
J Orthop Res; 2007 Apr; 25(4):465-72. PubMed ID: 17262821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
